Another study of lung adenocarcinoma (LUAD) patients analyzed RNA expression and somatic mutation data from The Cancer Genome Atlas (n = 516) to assess the overall survival (OS) and disease-free survival (DFS) based on the abundance of KRAS transcript variants (Yang and Kim, 2018). The gene discussed is KRAS; the disease is lung adenocarcinoma.